Search
T2EVOLVE: breakthrough alliance boosting Europe to the forefront of cancer immunotherapy
This press release is originally found here: http://prn. to/2YF7Js3
THE HAGUE, Netherlands, Feb. 3, 2021 /PRNewswire/ -- T2EVOLVE is a new breakthrough alliance of academic and industry leaders in cancer immunotherapy under the European Union's Innovative Medicines Initiative (IMI).
Meet Willem Fibbe, our volunteer of the month
Can you tell us what you do for EHA and when you started?
I have been involved in EHA over a period of twenty years, starting as counselor from 2000-2004.
Meet Willem Fibbe, our volunteer of the month
Can you tell us what you do for EHA and when you started?
I have been involved in EHA over a period of twenty years, starting as counselor from 2000-2004.
Highlights of Past EHA (HOPE) Asia 2023
EHA joined forces with the Indian Society of Hematology & Blood Transfusion (ISHBT) to organize the 5th edition of the Highlights of Past EHA (HOPE) Asia 2023 meeting.
Read moreMaster Class
Enhance your skills and expand your network with advanced online hematology training based on specially crafted clinical cases.
Read moreCall for SWG scientific meeting proposals
TThe next call will open at 09:00 CET on March 3, 2025. EHA provides financial support for specialized working group (SWG) scientific meetings to educate and share novel research findings.
Read more